Micron Enviro Systems, Inc. (OTCBB: MSVS) (FRANKFURT: NDDA) (”Micron”) has now been assigned a new symbol, which is MSVS. Micron has now commenced trading under the new symbol MSVS and no longer trades under the old symbols of MENV, MENVE or MSVSE. All shareholders will be entitled to receive the forward split shares upon surrender of their common shares. For shareholder who hold their shares through a brokerage house, they should contact their brokerage house directly for information on how the forward split will impact them.

The U.S. Food and Drug Administration (FDA) today cleared the OVA1(TM) Test, the first blood test that, prior to surgery, can help physicians determine if a woman is at risk for a malignant pelvic mass. OVA1 is the first FDA-cleared laboratory test that can indicate the likelihood of ovarian cancer with high sensitivity prior to biopsy or exploratory surgery, even if radiological test results fail

AQNM, Aquentium Inc, AQNM.OB

BONU, BioNeutral Group Inc, BONU.OB

SPNG, SpongeTech Delivery Systems Inc, SPNG.OB

DrStockPick.com Stock Report!

DrStockPick.com Report!

PennyOmega.com Announces Week’s Stock Watch! AQNM, BONU, SPNG

________________________________________

FREE Daily Stock Alerts From PennyOmega.com

________________________________________

DrStockPick.com Report!

Saturday August 29, 2009

**********************************************************

PennyOmega.com Announces Week’s

DrStockPick.com Stock Report!

Wednesday August 26, 2009

**************************************************************

Schering-Plough Corporation, (NYSE: SGP), today announced that the European Medicines Agency (EMEA) has validated (accepted for review) the company’s Marketing Authorization Application (MAA) for a fixed-dose combination of mometasone furoate and formoterol fumarate for the maintenance treatment of asthma in patients 12 years of age and older. The company also announced today that the EMEA has validated the MAA for nomegestrol acetate (2.5 mg) / 17 beta-estradiol (1.5mg), a combined oral contraceptive (COC) containing a unique combination of a natural estrogen identical to the estrogen produced by a woman’s own body and a selective progestin

Marathon Oil Corporation (NYSE: MRO) announced today

Trading on the OTCBB, BioNeutral Group, Inc. is a specialty chemical technology based Life Science Company. BioNeutral Group, Inc. intends to commercialize a combinational chemistry-based technology. This technology can neutralize harmful environmental contaminants, toxins, and dangerous microorganisms. These include bacteria, viruses, mold, fungi, and spores. The Company has their headquarters at the New Jersey Institute of Technology/EDC in Newark, New Jersey.

The Company’s formulations include Ygiene™ and Ogiene™, both of which are eco-friendly and include natural and common ingredients. The Company has combined these widely used compounds in highly specialized ways to create products that significantly enhance disinfecting and cleaning results. BioNeutral’s proprietary platform technology has proven effective in surface, water, and airborne applications. Products include BioNeutralizers and ChemoNeutralizers.

BioNeutralizers, based on the company’s proprietary Ygiene™ platform, disinfect, decontaminate, and sterilize. BioNeutral’s corporate mission is to bring to market the broadest-based, fastest acting, most effective and safest anti-microbial known. The

BioNeutral Group, Inc., a chemical technology-based life science company focused on commercializing a combinational chemistry-based technology that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms, recently announced the company has retained the Chertoff Group to provide strategic advisory services.

Based in Washington, D.C. and led by former Secretary of Homeland Security Michael Chertoff, the Chertoff Group is a security and risk management advisory firm that counsels corporate and government clients addressing threats related to terrorism, fraud, cyber security, border protection and supply chain security. Under the terms of this agreement, the Chertoff Group will focus on making preliminary recommendations for BioNeutral’s proprietary chemical technology for potential use in commercial and government health, defense and bio security markets in the United States.

Stephen J. Browand, president and chief executive officer of BioNeutral Group, Inc., stated, “We are excited to engage former Secretary Chertoff and his firm to assist us in our endeavors;

BioNeutral Group, Inc.’s proprietary Ogiene(TM) formulation is able to entrap and deliver the active chemical environment needed to eradicate a variety of noxious and toxic gases that harm the planet and threaten all who live on it. “This is a multi billion dollar opportunity and the impact will be extremely positive for countless industries across our country,” said Dr. Andy Kielbania, Ph.D., Chief Scientist at BioNeutral Group, Inc. “You can clearly see the results of our Ogiene(TM) formulation in a toxic smoke-filled fire situation illustrated in this field test video.”

Dr. Vasu Kulkarni, Ph.D., who specializes in Chemical and Environmental engineering and is a member of the Scientific Advisory Board added, “While more studies will be required, Ogiene(TM) technology may very well prove to be one of the most important control technologies available to address toxic and hazardous gases and it may extend its reach to address the precursor gases that

BioNeutral Group, Inc., a chemical technology-based Life Science company with novel combinational chemistry, announced today that it has signed a Letter of Intent (LOI) to acquire Orient Arts Inc., a manufacturer of fibers, textiles and finished goods. BioNeutral Group plans to acquire the company through an issuance of common shares.

Orient Arts and its affiliated companies are focused on manufacturing, designing and producing finished goods in Asia, the world’s largest and most populous continent. Generating collective annual sales of more than $10 million, Orient Arts and its affiliate companies have licensing agreements in place with several celebrities.

Stephen J. Browand, President and CEO of BioNeutral Group, Inc. commented, “Mahesh Lala is a seasoned executive in the field and we are fortunate that Mahesh has agreed to stay on board and continue to run Orient Arts. The company is interested in applying BioNeutral’s proprietary chemical formulations to the fabric and finished goods